The Treatment Effect for Asymptomatic Common Bile Duct Stone

Quality of Life Clinical Trial

Official title:

Multicenter Prospective Study for Efficacy of Asymptomatic Common Bile Duct Stone Treatment

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06215040
• Other study ID #: KNUH2023-09-029-001
• Status: Recruiting
• Start date: January 2, 2024
• Est. completion date: December 31, 2028

Study information

• Verified date: January 2024
• Source: Kyungpook National University Hospital
• Contact: Jun Heo
• Phone: 82532005505
• Email: hero797[@]hanmail.net
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is prospective, multicenter study for identify the characteristics of asymptomatic common bile duct stones and effectiveness of treatment.

Description:

There is no conflcts for treatment of symptomatic common bile duct stone. As more imaging examination such as healthy screening, more asymptomatic common bile duct stone patients are found. Current guideline for aymptomatic common bile duct stone is removal using endoscopic retrograde cholangiopancreatography. However, the previous studies that support this guideline included patients who just underwent cholecystectomy and were diagnosed as common bile duct stone. There is no prospective study for identify the treatment effectiveness of common bile duct stone removal in asymptomatic patients who are dignosed in healthy screening. Therefore, we are going to find the effectiveness of common bile duct stone removal by comparing questionnarie before and after removal of common bile duct stone in asymptomatic and incidentally found common bile duct stone patients. In addition, we are going to follow up patients who do not want to undergo common bile duct stone removal and find the rate of cholangitis risk. We also want to identify extact complication rate for endoscopic retrograde pancreatocholangiographic procedures in asymptomatic common bile duct stone.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. completion date: December 31, 2028
• Est. primary completion date: December 31, 2027
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• diagnosed as common bile duct stone by image modality examination

• agreement for this study enrollment

Exclusion Criteria:

• no definite common bile duct stone by image modality examination

• symptomatic patients who complain with fever/abdominal pain that compatible with common bile duct stone related symptom

• previously diagnosed as pancreatobiliary malignancy

• previously treated by endoscopic or percutaneous treatment for bile duct stones

• severe cardio or pulmonary disease

• pregnancy or possibility of pregnancy

• who do not agree with study enrollment

Related Conditions & MeSH terms

• Asymptomatic Condition
• Asymptomatic Diseases
• Choledocholithiasis
• Quality of Life

Intervention

Procedure:
• Endoscopic retrograde cholangiopancratography
common bile duct stone removal

Locations

Country	Name	City	State
Korea, Republic of	Kyungpook National University Hospital	Daegu	Gyungsangbok-do

Sponsors (6)

Lead Sponsor	Collaborator
Kyungpook National University Hospital	Daegu Catholic University Medical Center, Daegu Fatima Hospital, Keimyung University Dongsan Medical Center, Kyungpook National University Chilgok Hospital, Yeungnam University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Score of quality of life	Compare the quality of life before and after treatment	3 months